MIST – milestone pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China
Milestone Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Milestone Pharmaceuticals GAAP EPS of -$0.75, revenue of $1.55M [Seeking Alpha]
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT [Yahoo! Finance]
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session [Yahoo! Finance]
Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Trails Edge Capital Partners, LP
Form 3 Milestone Pharmaceutical For: Mar 17 Filed by: Sandoval David I.
Form 8-K Milestone Pharmaceutical For: Mar 20
Form 10-K Milestone Pharmaceutical For: Dec 31
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Bharucha David
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.